Virtual cGMP Training Marathon for Vaccine Manufacturing: Questions & Answers

Overview

In response to Member States’ requests for capacity building in the local production of quality-assured vaccines, the LPA Unit organized the Virtual cGMP Training Marathon for Vaccine Manufacturing (5 October to 11 November 2021) for vaccine and biopharmaceutical manufacturers, regulators, and government officials from the six WHO regions. Over 800 participants from more than 60 Member States in the six regions attended each of the 12 sessions in the training marathon to improve their knowledge, understanding and capacity to comply with WHO/international cGMP standards and requirements.

This document collates the questions raised during the 12 sessions and the answers from the good manufacturing practice (GMP) experts who delivered the training as a continuous learning resource for participants and other relevant stakeholders.